Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA; Division of Basic Research, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.
Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA; Division of Basic Research, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.
Cell Rep. 2022 Jun 14;39(11):110944. doi: 10.1016/j.celrep.2022.110944.
To better understand the functions of non-coding enhancer RNAs (eRNAs), we annotated the estrogen-regulated eRNA transcriptome in estrogen receptor α (ERα)-positive breast cancer cells using PRO-cap and RNA sequencing. We then cloned a subset of the eRNAs identified, fused them to single guide RNAs, and targeted them to their ERα enhancers of origin using CRISPR/dCas9. Some of the eRNAs tested modulated the expression of cognate, but not heterologous, target genes after estrogen treatment by increasing ERα recruitment and stimulating p300-catalyzed H3K27 acetylation at the enhancer. We identified a ∼40 nucleotide functional eRNA regulatory motif (FERM) present in many eRNAs that was necessary and sufficient to modulate gene expression, but not the specificity of activation, after estrogen treatment. The FERM interacted with BCAS2, an RNA-binding protein amplified in breast cancers. The ectopic expression of a targeted eRNA controlling the expression of an oncogene resulted in increased cell proliferation, demonstrating the regulatory potential of eRNAs in breast cancer.
为了更好地了解非编码增强子 RNA(eRNA)的功能,我们使用 PRO-cap 和 RNA 测序,对雌激素受体 α(ERα)阳性乳腺癌细胞中的雌激素调控的 eRNA 转录组进行注释。然后,我们克隆了鉴定出的 eRNA 中的一部分,将它们融合到单个向导 RNA 中,并使用 CRISPR/dCas9 将它们靶向到它们的 ERα 增强子起源处。经过雌激素处理后,一些经过测试的 eRNA 可以通过增加 ERα 募集和刺激增强子处的 p300 催化的 H3K27 乙酰化来调节同源但非异源靶基因的表达。我们鉴定出许多 eRNA 中存在一个约 40 个核苷酸的功能性 eRNA 调节基序(FERM),该基序对于雌激素处理后调节基因表达是必需和充分的,但不能调节激活的特异性。FERM 与 BCAS2 相互作用,BCAS2 是一种在乳腺癌中扩增的 RNA 结合蛋白。靶向 eRNA 的异位表达控制了致癌基因的表达,导致细胞增殖增加,证明了 eRNA 在乳腺癌中的调节潜力。